Clinical Genetics · Cincinnati, OH
NPI
1447281878
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3333 Burnet Ave Ml 4006
Cincinnati, OH, 45229
Phone (513) 636-4760
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,463
15 services
Medicare patients, 2024
14
Average age 50
Drug cost, 2024
$2.2M
110 prescriptions
Company payments, 2025
$69K
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Hopkin prescribed most often to Medicare patients was Fabrazyme (Agalsidase Beta), with 44 prescriptions and refills. In total Robert J Hopkin wrote 110 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fabrazyme Agalsidase Beta | 44 | 44 | Under 11 | $503K |
| Galafold Migalastat Hcl | 39 | 39 | Under 11 | $1.2M |
| Elfabrio Pegunigalsidase Alfa-Iwxj | 12 | 12 | Under 11 | $444K |
Brand drugs: 103 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Hopkin $69K ($69K in general payments such as food, travel and fees) from 7 companies. The largest payer was Amicus Therapeutics, Inc. with $30K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.